Journal Information

Discover cutting-edge pharmaceutical research in IJ Pharmaceutical Research. Indexed in SCIE, Scopus, and PubMed Central. JIF 2023: 1.8 | CiteScore 2023: 3.4.

JIF 2025

1.7

CiteScore 2025

2.9

First decision

28 days

Accept to publication

13 days

The record

Full journal title
IJ Pharmaceutical Research
Abbreviation
ijpr
NLM title
Iran J Pharm Res
Publisher
Brieflands
Scientific collaborator
School of Pharmacy, SBMU
e-ISSN
1726-6890
p-ISSN
1735-0328
Language
English
Frequency
annually
Publishing model
Per-article continuous
Subject area
Pharmacological research

Aim & scope

Iranian Journal of Pharmaceutical Research (IJPR) is a peer-reviewed, multidisciplinary scholarly journal dedicated to the dissemination of high-quality research and the advancement of knowledge in the field of pharmaceutical sciences. The journal is published annually and serves as an international platform for the exchange of scientific findings among researchers, clinicians, and industry professionals.

IJPR aims to promote innovative and impactful research that contributes to the understanding, development, evaluation, and rational use of pharmaceutical products and therapies. The journal particularly encourages submissions that integrate fundamental science with clinical and industrial applications.

The scope of the journal encompasses, but is not limited to, the following areas:

  • Pharmaceutical formulation and advanced drug delivery systems
  • Preformulation and physicochemical characterization of drug substances and dosage forms
  • Industrial pharmacy and pharmaceutical manufacturing sciences
  • Biopharmaceutics and pharmacokinetics
  • Medicinal chemistry and rational drug design
  • Computer-aided drug design and molecular modeling
  • Pharmacology and mechanism-based studies
  • Analytical method development and drug characterization
  • Pharmacognosy, phytochemistry, and bioactive natural products with pharmacological evaluation
  • Clinical pharmacology with a focus on drug-based interventions
  • Drug safety, toxicology, and risk assessment
  • Pharmacoeconomics and health outcomes research
  • Pharmaceutical biotechnology, nanomedicine, and targeted delivery systems

Article types

 

The IJPR considers a broad range of manuscript types that contribute to scientific knowledge, critical analysis, and scholarly discourse in the field. Submissions must demonstrate scientific rigor, methodological soundness, and relevance to the journal’s scope.

The following categories of manuscripts are accepted:

  • Original Research Articles
    • Full-length reports of original experimental or theoretical research that provide significant and novel findings in pharmaceutical sciences. Manuscripts should present clearly defined objectives, robust methodology, and comprehensive analysis of results.
  • Review Articles
    • Comprehensive and critical evaluations of existing literature in specific areas of pharmaceutical sciences. Reviews should provide insightful analysis, identify gaps in current knowledge, and propose future research directions.
  • Systematic Reviews and Meta-Analyses
    • Studies that employ structured and transparent methodologies to systematically collect, evaluate, and synthesize existing research findings. Meta-analyses should include appropriate statistical techniques to combine data from multiple studies.
  • Letters to the Editor
    • Scholarly communications that discuss, critique, or provide additional insights into articles previously published in the journal. Letters should be concise, evidence-based, and contribute constructively to academic discussion.

 

General Submission Considerations

All submitted manuscripts must be original, not previously published, and not under consideration for publication elsewhere. Submissions are subject to a rigorous peer-review process to ensure the quality, validity, and relevance of the published content.

Peer review

Access & licensing

License policy

This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Publication charges

Refer here

  • Publishing Open Access models: Full Gold Open Access
  • Access: Immediate permanent free to access after publication
  • Reader subscription fees: None
  • Article Processing Charge: Author pays APC
  • Embargo period: None
  • License for reuse: CC BY-NC 4.0
  • Publishing services: Full
  • Indexing: Full

Digital archiving

This journal deposits its articles in PMC and Portico to guarantee long-term digital preservation.

Indexing & metrics

Journal Metrics

Discover our most recent insights and updates.

JIF 20251.7
CiteScore 20252.9
Time to first decision28 days
Accept to publication13 days
Acceptance rate21%
Open peer review41
PubMed Centralon
Processing chargesMore

This journal is abstracted and indexed by a number of international services.

Complete list of indexing sources

Contact